logo
UCI Health Partner with Sierra Donor Services to Expand Kidney Transplant Opportunities Utilizing Paragonix KidneyVault Preservation Technology

UCI Health Partner with Sierra Donor Services to Expand Kidney Transplant Opportunities Utilizing Paragonix KidneyVault Preservation Technology

Business Wire29-05-2025

WALTHAM, Mass.--(BUSINESS WIRE)-- Paragonix Technologies, a pioneer in organ transplant technologies and organ procurement services, announced today a groundbreaking initiative with Sierra Donor Services and UCI Health to place high-risk donor kidneys, expanding transplant opportunities for patients in need.
, a nonprofit organ procurement organization (OPO) serving more than 2.8 million people across 13 counties in Northern California and Nevada, is leveraging this collaboration to successfully place kidneys that were previously deemed high risk due to donor complications, geographic limitations, and other logistical considerations.
Utilizing Paragonix's latest innovation—the KidneyVault Portable Renal Perfusion System —Sierra Donor Services has facilitated the transplantation of complex donor kidneys that had initially been declined due to factors such as donor age, cause of death, and underlying medical conditions. Through this technology, UCI Health has been able to transplant these organs successfully, demonstrating the transformative potential of advanced organ preservation in expanding the donor pool. The cutting-edge preservation system aims to combat key transplantation challenges by ensuring superior organ protection during transport and providing real-time monitoring of organ conditions and location.
UCI Health, one of California's largest academic health systems, is the clinical enterprise of the University of California, Irvine and one of the fastest growing kidney transplant centers on the west coast. UCI Health is at the forefront of transplant innovation, seeking new opportunities and technologies to both improve access to donor organs and post-transplant outcomes.
The lifesaving initiative is playing a critical role in addressing California's organ shortage by enabling the safe and effective utilization of kidneys that may have otherwise been potentially discarded. 'Currently, nearly 20,000 Californians are on the waiting list for a transplant, with 85% of them in need of a kidney. Last year over 9,000 kidneys recovered for transplant were ultimately unable to be used for a life saving transplant,' said Donna Smith, Chief Clinical Officer at Sierra Donor Services. 'The portable renal perfusion technology provided by KidneyVault gives us greater flexibility to place these much-needed organs, offering a second chance at life to patients who might not have otherwise received one.'
Dr. Robert R. Redfield, Chief of Transplantation at UCI Health, emphasized the importance of this innovative preservation system in expanding transplant opportunities. 'UCI Health is proud to have the oldest and largest kidney transplant program in Orange County, with survival outcomes exceeding the national average,' said Dr. Redfield. 'This technological improvement allows transplant centers like ours to consider more complex organs, as donations that must travel greater distances can now be perfused throughout the entire transplant journey.'
President of Paragonix Technologies, Dr. Lisa Anderson, PhD, echoed this sentiment, highlighting the company's commitment to honoring the gift of organ donation. 'Every organ donation is an incredible gift, and we believe it should be treated as such every single time,' said Dr. Anderson. 'With the KidneyVault Portable Renal Perfusion System, OPOs and transplant centers can confidently offer this life-saving gift to more patients by utilizing organs that previously would have gone unused.'
For more information about Paragonix Technologies, please visit paragonix.com
About Sierra Donor Services
Sierra Donor Services (SDS) serves nearly three million people in Northern California and Northern Nevada. We are an exceptional team of professionals dedicated to saving and improving lives by connecting organ and tissue donation to the patients who need them. We strive to extend the reach of each generous donor's gift to those who are always profoundly grateful for them. For more information, visit www.sierradonor.org.
About Paragonix Technologies
Paragonix Technologies is a leading developer, manufacturer, and service provider in the organ transplant industry, establishing a novel approach to organ preservation.
A Getinge company, Paragonix Technologies provides Advanced Organ Preservation ('AOP') devices that safeguard donor organs during the journey between donor and recipient patients. Our FDA-cleared and CE-marked devices incorporate clinically proven and medically trusted cold preservation techniques that allow unprecedented physical and thermal protection to the organ during transit. All Paragonix AOP devices are natively integrated with our novel digital app, delivering real-time organ tracking data and monitoring logistics for transplant teams seeking a secure and centralized solution. For more information, visit www.paragonix.com.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

We Need to Talk About Erectile Dysfunction: 38% of Canadian Men Don't Know You Need a Prescription for ED Medication
We Need to Talk About Erectile Dysfunction: 38% of Canadian Men Don't Know You Need a Prescription for ED Medication

Yahoo

time40 minutes ago

  • Yahoo

We Need to Talk About Erectile Dysfunction: 38% of Canadian Men Don't Know You Need a Prescription for ED Medication

– This Men's Health Week, Phoenix is addressing misconceptions around erectile dysfunction to raise awareness for treatment and break the social stigma – TORONTO, June 09, 2025--(BUSINESS WIRE)--For Men's Health Week (June 9 to 15), Phoenix, Canada's leading digital health clinic for men, is raising awareness to break the stigma around erectile dysfunction (ED), a medical condition that affects almost half (49.4%) of Canadian men aged 40 to 88. ED is a medical condition that prevents the ability to get and maintain an erection sufficient for sexual intercourse, with a range of potential causes that could each contribute to the condition, including age, medications, injury, and lifestyle. Despite its prevalence, Phoenix's survey of more than 1,500 Canadians found that there is a significant lack of awareness around ED and its treatment, likely contributing to stigma surrounding the condition. CANADIANS UNDERESTIMATE THE REACH OF ED Despite nearly half of Canadian men over 40 being affected, ED's prevalence is underestimated, driving undue stigma. In fact, almost half of Canadians (45%) think that ED affects less than 40 per cent of men 40+. Twenty-seven per cent of Canadians think it affects less than 30 per cent of men 40+. While Canadians underestimate the prevalence of ED in middle-aged and older men, many are also unaware that the condition can also impact younger men. The survey found that 64 per cent of Canadians don't know that men aged 35 and younger can experience ED. That percentage grows as you look at younger men, with 71% of Canadians unaware that men aged 18 to 25 can be affected. This common misconception can contribute to the stigma around experiencing ED as a younger man, making it more difficult for those struggling to seek care. "ED is a medical condition that men of all ages can experience. There shouldn't be anything awkward about it, but there is. We're trying to change that," says Kevin Bache, co-founder and co-CEO of Phoenix. "While it may feel uncomfortable, men need to understand what the condition entails, and not shy away from being proactive in discussing it with a doctor. The sooner you get started, the better your chances are at finding mental and physical relief." WIDESPREAD MISUNDERSTANDING OF ED MEDICATION Treatment for ED and its underlying cause can vary greatly depending on a patient's prognosis, however, medication is a common and effective treatment. Despite this fact, Phoenix's survey found 18 per cent of men are unsure if ED is treatable with medication, revealing a lack of awareness that may leave many suffering needlessly. The data also highlighted a concerning gap in awareness that ED medication requires a prescription. Thirty-eight per cent of men are unsure or don't think they need a prescription to purchase medication, such as Viagra, for ED. However, the lack of awareness is most significant among younger Canadians. About three in five Gen Z (59%) don't know that you need a prescription for ED medication: 32 per cent are unsure, and 27 per cent don't think you need a prescription at all. It is important that Canadians know that ED medication requires a prescription from a medical professional, as they may otherwise be vulnerable to purchasing unauthorized sexual enhancement products sold over the counter, which Health Canada warns could pose serious health risks. "It's no surprise that people aren't aware of the prevalence of ED – it just doesn't get talked about enough. But the good news is, there are treatment options, and with more openness and awareness, more people can seek support immediately," says Gavin Thompson, co-founder and co-CEO of Phoenix. "We built Phoenix to change that. Our mission is simple: make expert care easy to access – fast, discreet, and doctor-led. We're building a future where men take charge of their health with confidence." WHAT CANADIANS NEED TO KNOW ABOUT ED ED can affect men at any age, but it becomes more common as you get older. ED is more common than you may think, affecting almost half of Canadian men aged 40 to 88. Many factors can cause ED, including: low levels of testosterone, nervous dysfunction, blood flow complications, medications, medical conditions, lifestyle factors, obesity, diet, drug abuse, smoking, and emotional or psychological complications. ED is highly treatable, but the first step is consulting a medical professional. Treatment for erectile dysfunction and its underlying cause can vary greatly, making it important to consult a medical professional to receive a diagnosis and devise an effective treatment strategy. ED medication requires a prescription from a medical professional. Phoenix is currently available in Ontario, Alberta, British Columbia, Saskatchewan, Manitoba, Nova Scotia, New Brunswick, PEI, and Newfoundland. To learn more about Phoenix's ED support, visit ABOUT PHOENIX Phoenix is Canada's leading digital health clinic for men, specializing in three areas of treatment – erectile dysfunction, weight loss, and hair loss. The telehealth platform facilitates access to licensed Canadian physicians, treatment options, and free, discreet shipping of prescription medication from coast to coast. Visit to learn more. SURVEY METHODOLOGY These findings are from a survey conducted by Phoenix from May 20th to May 22nd, 2025, among a representative sample of 1509 online Canadians who are members of the Angus Reid Forum. The survey was conducted in English and French. For comparison purposes only, a probability sample of this size would carry a margin of error of +/-2.53 percentage points, 19 times out of 20. View source version on Contacts MEDIA Anne-Marie TrembleSenior Account Manager, Talk Shop Mediaannemarie@ 613-914-3551

Sesen Launches with a Singular Mission: Advancing Life Sciences Globally Through Specialized Language Solutions
Sesen Launches with a Singular Mission: Advancing Life Sciences Globally Through Specialized Language Solutions

Business Wire

timean hour ago

  • Business Wire

Sesen Launches with a Singular Mission: Advancing Life Sciences Globally Through Specialized Language Solutions

BOSTON--(BUSINESS WIRE)--Today marks the official launch of Sesen, a next-generation language services company purpose-built to meet the complex demands of the life sciences industry. Specializing exclusively in translation, localization, and AI-enhanced linguistic solutions for pharmaceutical, biotechnology, medical device, CRO, and regulatory organizations, Sesen combines industry expertise with cutting-edge technology to deliver fast, accurate, and fully compliant multilingual communications across 150+ languages. Built by industry veterans, Sesen is redefining how life sciences companies manage language workflows, from clinical trial documentation and regulatory labeling to patient communications and digital health platforms. At the core of its offering is SesenGPT, a proprietary AI engine trained on life sciences terminology and optimized for medical and regulatory content. Key Capabilities Include: Regulatory-compliant translations aligned with EMA, FDA, and PMDA guidelines ISO 17100, ISO 9001:2015, and ISO 13485:2016 certified quality management AI-enabled hybrid workflows for clinical trial translations, pharmacovigilance, and labeling Native linguists and MD/PhD medical reviewers for domain-specific accuracy Scalable language solutions integrated with sponsor CMS and eTMF systems 'Life sciences innovation is increasingly global, but language remains a critical barrier,' said Dr. Vladimir Misik, VP of Global Clinical Trial Strategy. 'We launched Sesen to solve this challenge with unmatched specialization, seamless technology integration, and the linguistic precision this industry demands.' Diego Di Leva, Sesen's VP of Global Operations, and a certified ISO 9001 and ISO 13485 auditor, added: "At Sesen, language quality is not an afterthought, it's built into the DNA of every project. Our quality assurance framework is grounded in international standards and supported by linguists with deep domain expertise, ensuring every deliverable meets the highest regulatory and scientific expectations." With a growing network of linguists, in-country reviewers, and regulatory consultants, Sesen supports top pharmaceutical and biotechnology companies with on-time, compliant delivery of multilingual assets for product launches, clinical trials, and regulatory submissions. About Sesen Sesen is a specialized language solutions provider exclusively serving the life sciences industry. Focused on clinical, regulatory, and commercial translation, Sesen supports pharmaceutical, biotech, medical device, and CRO clients in 150+ languages. The company combines native linguists, medical professionals, and ISO-certified workflows with proprietary AI technology to deliver faster, more accurate, and compliant content. From clinical trial support to product localization, Sesen enables life sciences organizations to operate with linguistic confidence and regulatory precision.

92% of Healthcare IT Leaders Believe They're Prepared to Prevent Email Breaches. They're Not.
92% of Healthcare IT Leaders Believe They're Prepared to Prevent Email Breaches. They're Not.

Business Wire

timean hour ago

  • Business Wire

92% of Healthcare IT Leaders Believe They're Prepared to Prevent Email Breaches. They're Not.

SAN FRANCISCO--(BUSINESS WIRE)--A new Paubox report shows just how off the mark healthcare IT leaders are about their email security. Based on first-party data from 150 U.S.-based healthcare IT leaders, the report reveals a dangerous confidence gap: leaders think they're covered, but the data says otherwise. 92% of healthcare IT leaders believe they're prepared to prevent email breaches. They're not. 'Healthcare IT is dangerously overconfident about email security,' reveals that 92% of healthcare IT leaders believe they're prepared to prevent email breaches. They're not. Most rely on outdated systems, tools that slow people down, and processes that actively undermine compliance. Organizations overestimate their security readiness, underinvesting in email security while forcing staff to work around clunky tools. Key findings from the report: 86% say their current tools create workflow friction, causing staff to bypass security processes 56% spend less than 10% of their security budget on email—despite it being the top threat vector Only 44% use AI-powered threat detection, even though 89% say it's critical 'We've seen email threats evolve faster than some of the tools meant to stop them,' said Hoala Greevy, Founder and CEO of Paubox. 'It's not just about phishing anymore—it's about deception at scale.' The report outlines the most common barriers IT leaders cited to adopting secure, compliant email solutions, including implementation complexity (54%), lack of vendor support (53%), and integration challenges with legacy systems (41%). These roadblocks create an environment where staff routinely bypass secure systems, putting patient data at risk. 'As a cybersecurity consulting practice engaging with hundreds of organizations annually, we consistently observe a critical gap in email security practices,' says Andrew Hicks, Partner and National HITRUST Practice Lead at Frazier & Dieter Advisory, LLC. 'Too often, organizations rely on infosec policies, user training, or manually enforced controls—rather than implementing automated, policy-driven email encryption solutions. This overreliance on human-dependent safeguards introduces unnecessary risk and undermines the integrity of outbound email protection strategies.' 'I see the gap in time between new vulnerabilities emerging and budgets catching up to them,' says Tony Cox, CIO for Henderson Behavioral Health. 'That delay? That's where the attackers live.' Why it matters: PHI isn't confined to EHRs. It flows through email, attachments, referrals, and coordination chains every day. Without strong email security safeguards in place, your compliance framework is one click away from collapse. Download the full report here: About Paubox Paubox offers HIPAA compliant communication solutions that empower healthcare organizations of any size to simply and securely communicate. Our suite of solutions includes HIPAA compliant encrypted email, inbound email security, HIPAA compliant email marketing, and HIPAA compliant email API for transactional communications. Our customers love our HITRUST certified solutions and we have industry-topping G2 ratings (4.9/5 stars). Learn more at

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store